Aurinia Pharmaceuticals (AUPH) Earnings
|
Expand Research on AUPH
| Next EPS Date | 7/31/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +255.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +12.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/30/26  |
Q126 | N/A | $0.19 | N/A | N/A | $75.29M | = | N/A | N/A | ||
| 2/26/26 | Q425 | $1.53 | $0.15 | +$1.38 | $77.1M | $74.41M | = |  | | Details | |
| 11/4/25 | Q325 | $0.23 | $0.16 | +$0.07 | $73.47M | $67.7M | = | | | Details | |
| 10/30/25 |
Q325 | N/A | $0.16 | N/A | N/A | $67.7M | = | N/A | N/A | ||
| 7/31/25 | Q225 | $0.16 | $0.14 | +$0.02 | $70M | $64.27M | = | | | Details | |
| 5/12/25 | Q125 | $0.16 | $0.11 | +$0.05 | $62.5M | $62.55M | = | | | Details | |
| 5/1/25 |
Q125 | N/A | $0.11 | N/A | N/A | $62.55M | = | N/A | N/A | ||
| 2/27/25 | Q424 | $0.01 | $0.03 | -$0.02 | $59.9M | $61.7M | = | | | Details |
